Suppr超能文献

程序性死亡受体 1 配体(PDL-1)阻断可抑制由减毒单核细胞增生李斯特菌引发的 T 细胞扩增和保护性免疫。

PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes.

作者信息

Rowe Jared H, Johanns Tanner M, Ertelt James M, Way Sing Sing

机构信息

Department of Pediatrics, Center for Infectious Disease and Microbiology Translational Research, University of Minnesota School of Medicine, Minneapolis, MN 55455, USA.

出版信息

J Immunol. 2008 Jun 1;180(11):7553-7. doi: 10.4049/jimmunol.180.11.7553.

Abstract

Infection with attenuated Listeria monocytogenes (Lm) is a robust in vivo model for examining how Ag-specific T cells are primed, and subsequent challenge with virulent Lm allows for the protective effects of T cell priming to be quantified. Herein, we investigated the role of programmed death ligand 1 (PDL-1) in T cell priming and immunity conferred after primary infection with Lm DeltaactA followed by virulent Lm challenge. In striking contrast to the inhibitory role of PDL-1 on T cell immunity in other infection models, marked reductions in the magnitude of T cell expansion and the kinetics of T cell proliferation were observed with PDL-1 blockade after primary Lm DeltaactA infection. More importantly, PDL-1 blockade beginning before primary infection and maintained throughout the experiment resulted in delayed bacterial clearance and T cell expansion after secondary challenge with virulent Lm. These results indicate that for immunity to intracellular bacterial infection, PDL-1 plays an important stimulatory role for priming and expansion of protective T cells.

摘要

感染减毒单核细胞增生李斯特菌(Lm)是一种用于研究抗原特异性T细胞如何被激活的强大体内模型,随后用毒力强的Lm进行攻击可对T细胞激活的保护作用进行量化。在此,我们研究了程序性死亡配体1(PDL-1)在初次感染Lm DeltaactA后再用毒力强的Lm攻击所赋予的T细胞激活和免疫中的作用。与PDL-1在其他感染模型中对T细胞免疫的抑制作用形成鲜明对比的是,在初次感染Lm DeltaactA后使用PDL-1阻断剂,观察到T细胞扩增幅度和T细胞增殖动力学显著降低。更重要的是,在初次感染前开始并在整个实验过程中维持的PDL-1阻断导致在用毒力强的Lm进行二次攻击后细菌清除延迟和T细胞扩增延迟。这些结果表明,对于细胞内细菌感染的免疫,PDL-1在保护性T细胞的激活和扩增中起重要的刺激作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11df/2677094/344ebe8427d9/nihms85979f1.jpg

相似文献

引用本文的文献

4
CMTM6 as a master regulator of PD-L1.CMTM6 作为 PD-L1 的主调控因子。
Cancer Immunol Immunother. 2022 Oct;71(10):2325-2340. doi: 10.1007/s00262-022-03171-y. Epub 2022 Mar 16.

本文引用的文献

2
PD-1 and its ligands in T-cell immunity.T细胞免疫中的程序性死亡受体1(PD-1)及其配体
Curr Opin Immunol. 2007 Jun;19(3):309-14. doi: 10.1016/j.coi.2007.04.012. Epub 2007 Apr 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验